Here are 10 articles on some of the most interesting medical research study findings and advancements from the week of May 23.
1. Italian researchers said the economic burden of managing needlestick and sharps injuries among healthcare personnel be offset by the savings generated by lowering these incidents in a new study. Read more.
2. New research presented at the 3rd World Congress on Acute Heart Failure demonstrates a potential link between flu vaccines and reduced hospitalization risk for heart failure patients. Read more.
3. Improving the location of sinks may increase hand hygiene compliance following contact with patients with Clostridium difficile infection, according to a study in BMC Infectious Diseases. Read more.
4. Although bothersome in a garden, English ivy produces one of the strongest adhesives in nature — and it could have medical applications, according to research from The Ohio State University in Columbus. Read more.
5. Compared to patients admitted to the hospital with non-sepsis infection, patients with sepsis have an increased risk of late death after discharge. Read more.
6. Colonoscopy patients who adhered to a low residue diet prior to the procedure reported higher satisfaction and were found to have better bowel preparations on average than patients who fasted, according to a new study. Read more.
7. Researchers revealed a rapid increase in pseudoscientific claims about Zika and a potential vaccine that coincided with an influx of media attention regarding the outbreak. The team's analysis recently appeared in Vaccine. Read more.
8. Vaccine uptake is relatively low among racial and ethnic minorities and the gap may have something to do with discrimination, according to new Medical Care study. Read more.
9. Recent ocular examinations of three infants born to Zika-infected mothers in Brazil suggest that the virus' potential impact on the vision of infants can be severe, perhaps resulting in blindness. Read more.
10. A strain of E. coli resistant to colistin — the antibiotic of last resort — was identified for the first time in the U.S. in April, marking "the emergence of a truly pan-drug resistant bacteria," according to a study in Antimicrobial Agents and Chemotherapy. Read more.